Control of hyperuricemia in subjects with refractory gout, and induction of antibody against poly(ethylene glycol) (PEG), in a phase I trial of subcutaneous PEGylated urate oxidase
-
* Corresponding author: Michael S Hershfield msh@biochem.duke.edu
Arthritis Research & Therapy 2006, 8:R12 doi:10.1186/ar1861
No comments have yet been made on this article.